微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -74.84% | -210.15% | -64.48% | 148/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -45.5% | -302.3% | -189.99% | 148/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -15.69% | -493.23% | 98.83% | 144/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -1341.82% | -2070.18% | -5460.8% | 149/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2023-09-30 | -24.13% | -124.05% | -113.35% | 145/159 | 2.34% | 百利天恒 | 186.1% | 行业排名> |
| 2023-06-30 | -11.31% | -152.46% | -383.46% | 138/159 | 1.46% | 百利天恒 | 186.89% | 行业排名> |
| 2023-03-31 | 3.99% | 9.62% | 106.45% | 18/159 | 1.37% | 百利天恒 | 188.56% | 行业排名> |
| 2022-12-31 | -61.83% | 45.88% | -474.09% | 146/159 | 0.67% | 小方制药 | 41.8% | 行业排名> |
| 2022-09-30 | -10.77% | -488.81% | -140.4% | 131/159 | 2.8% | 拓新药业 | 20.51% | 行业排名> |
| 2022-06-30 | -4.48% | -9.54% | -223.08% | 133/159 | 2.16% | 拓新药业 | 19.87% | 行业排名> |
| 2022-03-31 | 3.64% | -39.43% | 103.19% | 22/159 | 1.57% | 拓新药业 | 19.91% | 行业排名> |
| 2021-12-31 | -114.25% | -44.95% | -4224.55% | 147/159 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2021-09-30 | 2.77% | -40.69% | 167.73% | 95/159 | 4.43% | 福元医药 | 25.41% | 行业排名> |
| 2021-06-30 | -4.09% | 13.89% | -168.05% | 130/159 | 2.94% | 小方制药 | 34.81% | 行业排名> |
| 2021-03-31 | 6.01% | 6577.78% | 107.63% | 5/159 | 2.49% | 退市金泰 | 10.74% | 行业排名> |
| 2020-12-31 | -78.82% | -66.57% | -1787.79% | 142/159 | 3.58% | 人福医药 | 6.82% | 行业排名> |
| 2020-09-30 | 4.67% | 178.49% | 198.32% | 74/159 | 3.03% | 小方制药 | 71.99% | 行业排名> |
| 2020-06-30 | -4.75% | -416.3% | -5377.78% | 120/159 | 4.19% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-03-31 | 0.09% | -88.46% | 100.19% | 86/159 | 2.19% | 汇宇制药 | 28.14% | 行业排名> |
| 2019-12-31 | -47.32% | -791.81% | -695.29% | 130/159 | 2.53% | 哈三联 | 27.17% | 行业排名> |
| 2019-09-30 | -5.95% | -224.22% | -546.74% | 104/159 | 7.48% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-06-30 | -0.92% | -145.77% | -217.95% | 109/159 | 4.96% | 河化股份 | 45.32% | 行业排名> |
| 2019-03-31 | 0.78% | 23.81% | -88.6% | 88/159 | 2.41% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 6.84% | 14.19% | 42.8% | 69/159 | 6.99% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-09-30 | 4.79% | 13.78% | 138.31% | 70/159 | 7.18% | 奥赛康 | 35% | 行业排名> |
| 2018-06-30 | 2.01% | 0.5% | 219.05% | 81/159 | 4.6% | 奥赛康 | 28.15% | 行业排名> |
| 2018-03-31 | 0.63% | -54.35% | -89.48% | 87/159 | 2.54% | 宏源药业 | 21.91% | 行业排名> |
| 2017-12-31 | 5.99% | -57.06% | 42.28% | 77/159 | 9.61% | 奥赛康 | 9.7% | 行业排名> |
| 2017-09-30 | 4.21% | -43.79% | 110.5% | 66/159 | 8.29% | 奥赛康 | 40.69% | 行业排名> |
| 2017-06-30 | 2% | -57.81% | 44.93% | 82/159 | 5.58% | 信立泰 | 25.93% | 行业排名> |
| 2017-03-31 | 1.38% | -25.41% | -90.11% | 54/159 | 2.09% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | 13.95% | -15.86% | 86.25% | 38/159 | 6.19% | 奥赛康 | 12.08% | 行业排名> |
| 2016-09-30 | 7.49% | -24.27% | 58.02% | 38/159 | 5.61% | 一品红 | 31.62% | 行业排名> |
| 2016-06-30 | 4.74% | -26.05% | 156.22% | 39/159 | 3.48% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-03-31 | 1.85% | -40.71% | -88.84% | 45/159 | 2.65% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 16.58% | -38.04% | 67.64% | 30/159 | 11.27% | 华东医药 | 7.2% | 行业排名> |
| 2015-09-30 | 9.89% | 2% | 54.29% | 27/159 | 7.22% | 南新制药 | 81.7% | 行业排名> |
| 2015-06-30 | 6.41% | 101.02% | 105.45% | 26/159 | 4.87% | 德展健康 | 29.5% | 行业排名> |
| 2015-03-31 | 3.12% | -19.59% | -88.34% | 28/159 | 2.41% | 贝达药业 | 16.78% | 行业排名> |